Zor İyileşen Yaralar: Cerrahi Alan Enfeksiyonları ve Tedavisi
Özet
Cerrahi alan enfeksiyonları (CAE), modern cerrahi gelişmelere rağmen ameliyatların %3-20'sinde görülerek ciddi sosyoekonomik sonuçlara, tedavi giderlerinde artışa ve hastane yatış sürelerinin uzamasına yol açmaktadır. CDC tarafından yüzeyel insizyonel, derin insizyonel ve organ/boşluk ilişkili olarak üçe ayrılan CAE, kanıta dayalı önlemlerle %60'a kadar önlenebilmektedir. Enfeksiyon gelişiminde patojen özellikleri, yara yapısı ve hastaya ait diyabet, sigara kullanımı, obezite gibi risk faktörleri rol oynar; en sık rastlanan patojenler ise S. Aureus ve E. Coli'dir. Korunmada ameliyattan 30-60 dakika önce uygulanan antibiyotik profilaksisi (özellikle Sefazolin), alkol bazlı solüsyonlarla cilt hazırlığı, peroperatif normoterminin sağlanması ve triklosan kaplı antimikrobiyal sütür materyallerinin kullanımı etkinliği kanıtlanmış yöntemlerdir. Tedavide ise yaranın açılarak nekrotik dokuların debridmanı, pürülan drenajın sağlanması ve sorumlu patojenin direncine uygun antimikrobiyal terapi temel basamakları oluşturmaktadır. Günümüzde çoklu ilaç direncinin (MRSA ve Vankomisin dirençli E. Faeceum) artışı tedavi yönetimini zorlaştırmaktadır. Sonuç olarak, klinik başarıyı artırmak, mortalite ve morbiditeyi azaltmak için kanıta dayalı koruyucu önlemlere uyulması, erken teşhis ve multidisipliner tedavi yaklaşımı kritik öneme sahiptir.
Surgical site infections (SSIs) occur in 3-20% of operations despite modern surgical advances, leading to serious socioeconomic consequences, increased treatment costs, and prolonged hospital stays. Classified into three categories by the CDC as superficial incisional, deep incisional, and organ/space infections, SSIs can be prevented by up to 60% through evidence-based measures. Pathogen characteristics, wound properties, and patient-related risk factors such as diabetes, smoking, and obesity play a role in development, with S. Aureus and E. Coli being the most common pathogens. Proven preventive methods include antibiotic prophylaxis (especially Cefazolin) administered 30-60 minutes before surgery, skin preparation with alcohol-based solutions, maintaining perioperative normothermia, and utilizing triclosan-coated antimicrobial suture materials. Treatment relies on opening the wound for debridement of necrotic tissues, ensuring purulent drainage, and administering antimicrobial therapy tailored to the resistance of the responsible pathogen. Today, the rise of multidrug resistance (such as MRSA and Vancomycin-resistant E. Faeemum) complicates treatment management. Consequently, adhering to evidence-based preventive measures, early diagnosis, and a multidisciplinary treatment approach are critically important to improve clinical outcomes and reduce mortality and morbidity.
Referanslar
Piednoir E, Robert-Yap J, Baillet P, Lermite E, Christou N. The Socioeconomic Impact of Surgical Site Infections. Front Public Health. 2021;9:712461.
Brigid MG, Emma H, Megan R, Rhea L, Rachel W, Sharon L, et al. Worldwide incidence of surgical site infections in general surgical patients: A systematic review and meta-analysis. Int J Surg. 2021:106136.
Badia JM, Casey AL, Petrosillo N, Hudson PM, Mitchell SA, Crosby C. Impact of surgical site infection on healthcare costs and patient outcomes: a systematic review in six European countries. J Hosp Infect. 2017;96(1):1-15.
Prevention. CfDCa. Centers for Disease Control and Prevention. The National Healthcare Safety Network (NHSN) Manual: Patient Safety Component. Atlanta (GA): Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases 2021 [Available from: https://www.cdc.gov/nhsn/pdfs/pscmanual/9pscssicurrent.pdf.
Garner BH, Anderson DJ. Surgical Site Infections: An Update. Infect Dis Clin North Am. 2016;30(4):909-29.
National Nosocomial Infections Surveillance (NNIS) System Report, Data Summary from January 1990-May 1999, issued June 1999. A report from the NNIS System. Am J Infect Control. 1999;27(6):520-32.
Durand F, Berthelot P, Cazorla C, Farizon F, Lucht F. Smoking is a risk factor of organ/space surgical site infection in orthopaedic surgery with implant materials. International Orthopaedics. 2013;37(4):723-7.
Dronge AS, Perkal MF, Kancir S, Concato J, Aslan M, Rosenthal RA. Long-term Glycemic Control and Postoperative Infectious Complications. Archives of Surgery. 2006;141(4):375-80.
Ban KA, Minei JP, Laronga C, Harbrecht BG, Jensen EH, Fry DE, et al. American College of Surgeons and Surgical Infection Society: Surgical Site Infection Guidelines, 2016 Update. J Am Coll Surg. 2017;224(1):59-74.
Kwon S, Thompson R, Dellinger P, Yanez D, Farrohki E, Flum D. Importance of perioperative glycemic control in general surgery: a report from the Surgical Care and Outcomes Assessment Program. Ann Surg. 2013;257(1):8-14.
Mohamed R, Wall J, Arumainathan R, Fink D, Sandhu T, Garg S, et al. Assessing antibiotic stewardship using the surgical site infection prevention bundle. Br J Hosp Med (Lond). 2018;79(11):643-7.
Allen J, David M, Veerman JL. Systematic review of the cost-effectiveness of preoperative antibiotic prophylaxis in reducing surgical-site infection. BJS Open. 2018;2(3):81-98.
Berríos-Torres SI, Umscheid CA, Bratzler DW, Leas B, Stone EC, Kelz RR, et al. Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection, 2017. JAMA Surgery. 2017;152(8):784-91.
Luwang AL, Saha PK, Rohilla M, Sikka P, Saha L, Gautam V. Chlorhexidine-alcohol versus povidone-iodine as preoperative skin antisepsis for prevention of surgical site infection in cesarean delivery-a pilot randomized control trial. Trials. 2021;22(1):540.
Dumville JC, McFarlane E, Edwards P, Lipp A, Holmes A, Liu Z. Preoperative skin antiseptics for preventing surgical wound infections after clean surgery. Cochrane Database Syst Rev. 2015;2015(4):Cd003949.
Seamon MJ, Wobb J, Gaughan JP, Kulp H, Kamel I, Dempsey DT. The effects of intraoperative hypothermia on surgical site infection: an analysis of 524 trauma laparotomies. Ann Surg. 2012;255(4):789-95.
Melling AC, Ali B, Scott EM, Leaper DJ. Effects of preoperative warming on the incidence of wound infection after clean surgery: a randomised controlled trial. Lancet. 2001;358(9285):876-80.
Wong PF, Kumar S, Bohra A, Whetter D, Leaper DJ. Randomized clinical trial of perioperative systemic warming in major elective abdominal surgery. Br J Surg. 2007;94(4):421-6.
Pinkney TD, Calvert M, Bartlett DC, Gheorghe A, Redman V, Dowswell G, et al. Impact of wound edge protection devices on surgical site infection after laparotomy: multicentre randomised controlled trial (ROSSINI Trial). Bmj. 2013;347:f4305.
Mihaljevic AL, Schirren R, Özer M, Ottl S, Grün S, Michalski CW, et al. Multicenter double-blinded randomized controlled trial of standard abdominal wound edge protection with surgical dressings versus coverage with a sterile circular polyethylene drape for prevention of surgical site infections: a CHIR-Net trial (BaFO; NCT01181206). Annals of surgery. 2014;260(5):730-7; discussion 7-9.
Reid K, Pockney P, Draganic B, Smith SR. Barrier wound protection decreases surgical site infection in open elective colorectal surgery: a randomized clinical trial. Dis Colon Rectum. 2010;53(10):1374-80.
Guo J, Pan LH, Li YX, Yang XD, Li LQ, Zhang CY, et al. Efficacy of triclosan-coated sutures for reducing risk of surgical site infection in adults: a meta-analysis of randomized clinical trials. J Surg Res. 2016;201(1):105-17.
Ahmed I, Boulton AJ, Rizvi S, Carlos W, Dickenson E, Smith NA, et al. The use of triclosan-coated sutures to prevent surgical site infections: a systematic review and meta-analysis of the literature. BMJ Open. 2019;9(9):e029727.
Wang ZX, Jiang CP, Cao Y, Ding YT. Systematic review and meta-analysis of triclosan-coated sutures for the prevention of surgical-site infection. Br J Surg. 2013;100(4):465-73.
Weiner-Lastinger LM, Abner S, Edwards JR, Kallen AJ, Karlsson M, Magill SS, et al. Antimicrobial-resistant pathogens associated with adult healthcare-associated infections: Summary of data reported to the National Healthcare Safety Network, 2015–2017. Infection Control & Hospital Epidemiology. 2020;41(1):1-18.
